Lantern Pharma Inc.
LTRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,332 | $46,405 | $65,537 | $87,021 |
| - Cash | $7,511 | $21,938 | $37,202 | $51,524 |
| + Debt | $244 | $234 | $53 | $205 |
| Enterprise Value | $27,064 | $24,702 | $28,389 | $35,702 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$175 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22,199 | -$15,787 | -$14,423 | -$12,585 |
| % Margin | – | – | – | – |
| Net Income | -$20,781 | -$15,962 | -$14,260 | -$12,363 |
| % Margin | – | – | – | – |
| EPS Diluted | -1,930.92 | -1.47 | -1.31 | -1.13 |
| % Growth | -131,255.1% | -12.2% | -15.9% | – |
| Operating Cash Flow | -$17,813 | -$14,347 | -$12,767 | -$10,592 |
| Capital Expenditures | -$13 | -$19 | -$28 | -$15 |
| Free Cash Flow | -$17,826 | -$14,365 | -$12,795 | -$10,607 |